|
|
|
|
Federal |
Non-Federal |
| UDDS |
Account Name |
Agency |
P.I. |
Esno Notice Amount |
Esno Notice Amount |
| Msn/Med Sc/Administration/Rural Hlth |
STATE OFFICES OF RURAL HEALTH PROGRAM |
Dhhs, Phs, Health Resources And Services Admin |
MOSKOL, FREDRIC E |
64,000.00 |
|
| Msn/Med Sc/Acad Affairs/Stu Serv-Rec |
2000 NASA SHARP PLUS APPRENTICESHIP PROGRAM |
Quality Education For Minorities Network |
HAWKINS, GLORIA V |
24,350.00 |
|
| Msn/Med Sc/Anatomy/Anatomy |
CHARACTERIZATION OF HORMONE RECEPTORS AND |
Inter, Us Geological Survey |
FALLON, JOHN F |
-11,064.68 |
|
| Msn/Med Sc/Anesthesiology/Anesthesio |
A MULTICENTER STUDY OF OUTCOMES IN PATIENTS |
Ischemia Research And Education Foundation |
MCSWEENEY, MARY E |
|
5,000.00 |
| Msn/Med Sc/Anesthesiology/Anesthesio |
TRAMAP-PEDS-001 EVALUATION OF THE SAFETY PROFILE |
Johnson (R.W.) Pharmaceutical Research Institute |
PROCTOR, LESTER T |
|
5,912.00 |
| Msn/Med Sc/Biostat & Med I/Biost&M
I |
DATA ANALYSIS CENTER FOR THE COMPANION STUDY |
Clinical Cardiovascular Research Llc |
DEMETS, DAVID L |
|
42,383.00 |
| Msn/Med Sc/Family Medicine/Addctn Med |
INTEGRATION OF FETAL ALCOHOL EXPOSURE CLINICIANS' |
Dhhs, Phs, National Institutes Of Health |
FLEMING, MICHAEL F |
60,652.00 |
|
| Msn/Med Sc/Family Medicine/Family Med |
DEVELOPMENT OF A HEADACHE TEACHING PROGRAM |
Glaxo Wellcomme |
RIFKIN, ALLAN R |
|
15,000.00 |
| Msn/Med Sc/Genetics/Genetics |
SHAW SCIENTIST 1996-2001 |
Milwaukee Foundation |
PETRINI, JOHN H J |
|
20,000.00 |
| Msn/Med Sc/Genetics/Genetics |
3 UTR CONTROL OF TRA-2 TRANSLATION IN C ELEGANS |
Dhhs, Phs, National Institutes Of Health |
GOODWIN, ELIZABETH B |
21,724.00 |
|
| Msn/Med Sc/Genetics/Genetics |
MOLECULAR ANALYSIS OF CD8, MHC CLASS I |
Yale University |
DEMARS, ROBERT I |
12,500.00 |
|
| Msn/Med Sc/Obstet & Gynecol/Ob-Gyn |
DEFRAY EXPENSES IN CONNECTION WITH DUTIES AS |
American Society For Colposcopy And |
JULIAN, THOMAS M |
|
31,649.75 |
| Msn/Med Sc/Obstet & Gynecol/Ob-Gyn |
MECHANISMS OF PREGNANCY-INDUCED AT-1 RECEPTOR |
Dhhs, Phs, National Institutes Of Health |
BIRD, IAN M |
100,800.00 |
|
| Msn/Med Sc/Human Oncology/Human Onco |
PHYSICS DEVELOPMENT |
Adac Laboratories |
TOME, WOLFGANG |
|
25,000.00 |
| Msn/Med Sc/Human Oncology/Rad Therap |
RADIATION THERAPY ONCOLOGY GROUP |
American College Of Radiology |
HARARI, PAUL M |
8,900.00 |
|
| Msn/Med Sc/Comp Cancer Ctr/Cancer Ctr |
04731L/0010 PHASE 1 TRIAL OF ZD0473 AND |
Astrazeneca |
SCHILLER, JOAN H |
|
27,256.00 |
| Msn/Med Sc/Comp Cancer Ctr/Clin Oncol |
B9E-MC-X115: PHASE 11 STUDY OF GEMCITABINE,
5- |
Lilly (Eli) And Company |
STEWART, JAMES A |
|
26,250.00 |
| Msn/Med Sc/Comp Cancer Ctr/Clin Oncol |
BONE MINERAL DENSITY EFFECTS OF ZOLEDRONATE
IN |
Novartis |
LOVE, RICHARD R |
|
50,000.00 |
| Msn/Med Sc/Comp Cancer Ctr/Clin Oncol |
PHASE 11 TRIAL OF AMINOPTERIN IN PATIENTS WITH |
Ilex Oncology, Inc. |
HARTENBACH, ELLEN M |
|
6,447.60 |
| Msn/Med Sc/Comp Cancer Ctr/Clin Oncol |
RAND COST OF CANCER TREATMENT STUDY |
Rand |
STEWART, JAMES A |
|
250.00 |
| Msn/Med Sc/Comp Cancer Ctr/Pain Study |
BUILDING CAPACITY TO PROMOTE PAIN POLICY |
Johnson (Robert Wood) Foundation |
JORANSON, DAVID E |
|
520,558.00 |
| Msn/Med Sc/Comp Cancer Ctr/Prev Oncol |
MELVIN YOUTH TOBACCO PREVENTION PROGRAM - |
Wisc Dept Of Health And Family Services |
REMINGTON, PATRICK L |
|
50,250.00 |
| Msn/Med Sc/Comp Cancer Ctr/Prev Oncol |
THOMAS T. MELVIN S.E. URBAN PARTNERSHIP |
Wisc Dept Of Health And Family Services |
REMINGTON, PATRICK L |
|
100,000.00 |
| Msn/Med Sc/Comp Cancer Ctr/Prev Oncol |
CANCER INFORMATION SERVICE |
Dhhs, Phs, National Institutes Of Health |
REMINGTON, PATRICK L |
1,082,888.00 |
|
| Msn/Med Sc/Inst Aging/Inst Aging |
162-00 A TWELVE-WEEK, MULTI-CENTER, DOUBLE-BLIND, |
Merck & Co., Inc. |
BINKLEY, NEIL C |
|
2,100.00 |
| Msn/Med Sc/Inst Aging/Inst Aging |
H3S-MC-GGJY CONTINUING OUTCOMES RELEVANT TO
EVISTA |
Lilly (Eli) And Company |
BINKLEY, NEIL C |
|
10,970.30 |
| Msn/Med Sc/Medicine/Allrgy&Imm |
DOES SALMETEROL HAVE ADDITIVE EFFECTS TO |
Glaxo Wellcome Inc. |
BUSSE, WILLIAM W |
|
20,000.00 |
| Msn/Med Sc/Medicine/Allrgy&Imm |
GLAXO 30030: A DOUBLE-BLIND, DOUBLE-DUMMY, |
Pharmaceutical Reserach Associates, In. |
BUSSE, WILLIAM W |
|
34,125.00 |
| Msn/Med Sc/Medicine/Allrgy&Imm |
P001998-04 LORATADINE/MONTELUKAST COMBINATION |
Schering-Plough Corporation |
BUSSE, WILLIAM W |
|
7,875.00 |
| Msn/Med Sc/Medicine/Allrgy&Imm |
P00340, EFFICACY AND SAFETY STUDY OF MOMETASONE |
Schering-Plough Research Institute |
BUSSE, WILLIAM W |
|
12,312.00 |
| Msn/Med Sc/Medicine/Allrgy&Imm |
SAS 40020 - A RADOMIZED, DOUBLE-BLIND, DOUBLE- |
Ctms, Inc. |
BUSSE, WILLIAM W |
|
22,358.33 |
| Msn/Med Sc/Medicine/Allrgy&Imm |
SAS40027 A RANDOMIZED, BOUBLE-BLIND, PARALLEL |
Pharmaceutical Reserach Associates, Inc. |
BUSSE, WILLIAM W |
|
8,420.00 |
| Msn/Med Sc/Medicine/Allrgy&Imm |
SB207499/110: A 12-WEEK, MULTICENTER, DOUBLE-BLIND |
Smithkline Beecham |
BUSSE, WILLIAM W |
|
22,818.00 |
| Msn/Med Sc/Medicine/Allrgy&Imm |
ASTHMA CLINICAL RESEARCH NETWORK (ACRN) |
Dhhs, Phs, National Institutes Of Health |
LEMANSKE, ROBERT F |
667,343.00 |
|
| Msn/Med Sc/Medicine/Cardiology |
COMPARISON OF NONINVASIVE INFRASONIC CARDIOGRAPHY |
Bioacoustics, Inc. |
STONE, CHARLES K |
|
1,200.00 |
| Msn/Med Sc/Medicine/Cardiology |
CVAL489 0108 MULTINATIONAL, MULTICENTER, STUDY |
Duke Clinical Research Insitute |
ENDE, DAVID J |
|
3,600.00 |
| Msn/Med Sc/Medicine/Endocrinol |
BRL49653C/137-A STUDY TO EVALUATE THE EFFICACY
OF |
Smithkline Beecham Pharmaceuticals |
MEREDITH, MELISSA |
|
1,855.80 |
| Msn/Med Sc/Medicine/Endocrinol |
HOE901/4002-TARGET GLYCEMIC CONTROL AND THE |
Quintiles, Inc. |
MEREDITH, MELISSA |
|
3,137.00 |
| Msn/Med Sc/Medicine/Gastroent |
A TWELVE-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO- |
Icon Clinical Research Inc. |
REICHELDERFER, MARK |
|
1,045.56 |
| Msn/Med Sc/Medicine/Gen Int Md |
IMPROVING SMOKING CESSATION SUCCESS BY |
Robert Wood Johnson Foundation |
FIORE, MICHAEL C |
|
105,737.00 |
| Msn/Med Sc/Medicine/Hematology |
A PHASE 11 MULTICENTER STUDY OF PENTOSTATIN |
Supergen, Inc. |
MOSHER, DEANE F |
|
9,000.00 |
| Msn/Med Sc/Medicine/Hematology |
ABERRANT HEMODYNAMIC FORCES PREDISPOSE |
Berlex Laboratories, Inc. |
LELKES, PETER I |
|
37,312.50 |
| Msn/Med Sc/Medicine/Hematology |
ADULT HEMOPHILIA PROGRAM |
American Red Cross |
WILLIAMS, ELIOT C |
|
4,250.00 |
| Msn/Med Sc/Medicine/Infect Dis |
CAPSS-118/L0FBIV-NEUT-001 PHASE 3B MULTICENTER, |
Advanced Biologics |
MAKI, DENNIS G |
|
4,800.00 |
| Msn/Med Sc/Medicine/Infect Dis |
M/1260/0025 LINEZOLID (PNU-100766) GIVEN |
Covance |
MAKI, DENNIS G |
|
1,750.00 |
| Msn/Med Sc/Medicine/Infect Dis |
HOST-PATHAGEN INTERACTIONS IN VIRAL REPLICATION |
Dhhs, Phs, National Institutes Of Health |
MILLER, DAVID J |
129,735.00 |
|
| Msn/Med Sc/Medicine/Pulmon Med |
EPIDEMIOLOGIC STUDY OF CYSTIC FIBROSIS: A |
Clintrials Research, Inc. |
DOPICO, GUILLERMO A |
|
1,675.00 |
| Msn/Med Sc/Medicine/Rheumatol |
CS-L2-9901 A PHASE 111 MULTICENTER, RANDOMIZED |
Chiron Corporation |
GRAZIANO, FRANK M |
|
3,941.00 |
| Msn/Med Sc/Medicine/Rheumatol |
ESS-40011 A 24 WEEK, RANDOMIZED, OPEN-LABEL, |
Kern Mcneill International |
GRAZIANO, FRANK M |
|
3,500.00 |
| Msn/Med Sc/Medicine/Rheumatol |
M98-863 A RANDOMIZED, DOUBLE-BLIND, PHASE 111 |
Pharmaceutical Product Development Pharmaco,
Inc. |
GRAZIANO, FRANK M |
|
3,324.00 |
| Msn/Med Sc/Women Health&Res/Women Hlth |
DES NATIONAL EDUCATION CAMPAIGN: HEALTH |
Dhhs, Office Of The Secretary |
CARNES, MARY L |
25,000.00 |
|
| Msn/Med Sc/Women Health&Res/Women Hlth |
NATIONAL CENTERS OF EXCELLENCE IN WOMEN'S HEALTH |
Dhhs, Office Of The Secretary |
CARNES, MARY L |
176,279.00 |
|
| Msn/Med Sc/Med Microbiology/Med Micro |
MECHANISM OF ACTION OF SURFACTANTS ON |
Kimberly-Clark Corporation |
PROCTOR, RICHARD A |
|
92,794.00 |
| Msn/Med Sc/Med Microbiology/Med Micro |
RESEARCH AGREEMENT - TESTING ABILITY OF PFIZER |
Pfizer, Inc. |
BYRNE, GERALD I |
|
20,160.00 |
| Msn/Med Sc/Med Microbiology/Med Micro |
T CELL RECEPTOR USAGE AND PULMONARY HISTOPLASMOSIS |
University Of Cincinnati |
WOODS, JON P |
45,567.00 |
|
| Msn/Med Sc/Medical Physics/Med Physic |
LESCRENIER FELLOWSHIP |
Gammex Rmi |
CHAIR |
|
34,782.00 |
| Msn/Med Sc/Hs Libraries/Hs Library |
IMPROVING WEB-BASED ACCESS AND DELIVERY OF
HEALTH |
Eastern Wi Area Health Education Center (Ahec) |
DIRECTOR |
10,020.00 |
|
| Msn/Med Sc/Hs Libraries/Hs Library |
SOUTHWEST WISCONSIN HEALTH INFORMATION ACCESS |
Southwest Wi Area Health Education Center (Ahec) |
DIRECTOR |
15,410.00 |
|
| Msn/Med Sc/Neurology/Neurology |
ZNS-502 A MULTICENTER, OPEN LABLE, SAFTY AND |
Elan Pharmaceuticals |
SHETH, RAJ D |
|
4,263.60 |
| Msn/Med Sc/Neuro Surg/Neuro Surg |
ESIT ENDOSCOPIC SHUNT INSERTION TRIAL |
British Columbia (University Of) |
ISKANDAR, BERMANS J |
|
800.00 |
| Msn/Med Sc/Oncology/Oncology |
DEVELOPMENT OF NEW TERPENE ANALOGS FOR CANCER |
Wisconsin Genetics Inc. |
GOULD, MICHAEL N |
|
25,000.00 |
| Msn/Med Sc/Oncology/Oncology |
A NOVEL STRATEGY FOR TARGETING RETROVIRAL VECTORS |
Dod, Army |
YOUNG, JOHN |
124,328.48 |
|
| Msn/Med Sc/Oncology/Oncology |
STRATEGIES TO INHIBIT CELLULAR UPTAKE OF ANTHRAX |
Dhhs, Phs, National Institutes Of Health |
YOUNG, JOHN |
314,839.00 |
|
| Msn/Med Sc/Oncology/Oncology |
USE OF RETROVIRALLY MEDIATED RAT MAMMARY MODEL |
Dhhs, Phs, National Institutes Of Health |
GOULD, MICHAEL N |
495,826.00 |
|
| Msn/Med Sc/Ophthal&Vis Sci/Oph&Vis
Sc |
AG3340-801 A PHASE 11, RANDOMIZED, DOUBLE-MASKED, |
Agouron Pharmaceuticals |
STEVENS, THOMAS S |
|
1,450.00 |
| Msn/Med Sc/Ophthal&Vis Sci/Oph&Vis
Sc |
B7A-MC-MBBK (B) PROTEIN KINASE C INHIBITOR
B - |
Lilly (Eli) And Company |
GOTTLIEB, JUSTIN L |
|
6,018.00 |
| Msn/Med Sc/Ophthal&Vis Sci/Oph&Vis
Sc |
B7A-MC-MBBM(B) PROTEIN KINASE C INHIBITOR B |
Lilly (Eli) And Company |
GOTTLIEB, JUSTIN L |
|
6,132.00 |
| Msn/Med Sc/Ophthal&Vis Sci/Oph&Vis
Sc |
AGE RELATED EYE DISEASE STUDY |
Dhhs, Phs, National Institutes Of Health |
CHANDRA, SURESH R |
327,067.00 |
|
| Msn/Med Sc/Ophthal&Vis Sci/Oph&Vis
Sc |
AGE-RELATED EYE DISEASES STUDY (AREDS) - |
Dhhs, Phs, National Institutes Of Health |
DAVIS, MATTHEW D |
642,655.00 |
|
| Msn/Med Sc/Pathol & Lab Med/Anat Path |
THE ROLE OF MNSOD IN DRUG RESISTANCE AND CARDIAC |
The University Of Kentucky Research Foundation |
OBERLEY, TERRY D |
56,831.00 |
|
| Msn/Med Sc/Pediatrics/Pediatrics |
A STUDY OF THE SAFETY, TOLERANCE AND EFFICACY
OF |
Ppd Development |
NEISH, STEVEN R |
|
5,663.00 |
| Msn/Med Sc/Pediatrics/Pediatrics |
AIRWAY SECRETION CLEARENACE IN CYSTIC FIBROSIS |
Children'S Hospital |
ROCK, MICHAEL J |
|
1,000.00 |
| Msn/Med Sc/Pediatrics/Pediatrics |
ANALYSIS OF TRACHEAL SECRETIONS TO DETERMINE
IF |
American Academy Of Pediatrics |
GERN, JAMES E |
|
2,000.00 |
| Msn/Med Sc/Pediatrics/Pediatrics |
C98-477-08: A DOUBLE-BLIND STUDY OF THE EFFECTS |
Schering Plough Research Institute |
LEMANSKE, ROBERT F |
|
1,530.00 |
| Msn/Med Sc/Pediatrics/Pediatrics |
PEDIATRICS DIABETES CENTER |
University Of Wisconsin Foundation |
MACDONALD, MICHAEL J |
|
80,000.00 |
| Msn/Med Sc/Pediatrics/Pediatrics |
Z0595N EPIDEMIOLOGIC STUDY OF CYSTIC FIBROSIS: |
Clintrials Research, Inc. |
GREEN, CHRISTOPHER G |
|
8,025.00 |
| Msn/Med Sc/Pediatrics/Pediatrics |
GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY |
Dhhs, Phs, National Institutes Of Health |
WOLFF, JON A |
83,020.00 |
|
| Msn/Med Sc/Pharmacology/Pharmacology |
MECHANISMS OF CONSTITUTIVE NF-KB ACTIVITY |
Dhhs, Phs, National Institutes Of Health |
MIYAMOTO, SHIGEKI |
188,531.00 |
|
| Msn/Med Sc/Biomolec Chem/Biomol Chm |
POSTDOCTORAL INDIVIDUAL NATIONAL RESEARCH |
Dhhs, Phs, National Institutes Of Health |
BERTICS, PAUL J |
40,936.00 |
|
| Msn/Med Sc/Physiology/Physiology |
MODULATORY MECHANISMS OF RYANODINE RECEPTOR |
Dhhs, Phs, National Institutes Of Health |
VALDIVIA, HECTOR H |
252,000.00 |
|
| Msn/Med Sc/Preventive Med/Preven Med |
WOMEN'S HEALTH INITIATIVE-MEMORY STUDY |
Bowman Gray School Of Medicine |
ALLEN, CATHERINE I |
|
6,451.00 |
| Msn/Med Sc/Preventive Med/Preven Med |
CONSORTIUM OF THE HEALTH ASSESSMENT OF GREAT |
Wi Dept Of Health & Family Services |
KANAREK, MARTY S |
44,740.00 |
|
| Msn/Med Sc/Preventive Med/Preven Med |
HUMAN VENTILATORY ADAPTATION |
Dhhs, Phs, National Institutes Of Health |
DEMPSEY, JEROME A |
232,651.00 |
|
| Msn/Med Sc/Preventive Med/Preven Med |
OUTCOMES AND QUALITY OF LIFE MEASURES FOR ACRIN |
American College Of Radiology |
FRYBACK, DENNIS G |
40,000.00 |
|
| Msn/Med Sc/Psychiatry/Psychiatry |
WI PUBLIC PSYCHIATRY NETWORK |
Wi Dept Of Health And Family Services |
DIAMOND, RONALD J |
86,625.00 |
|
| Msn/Med Sc/Csrem/Csrem |
ETHNIC MINORITIES AS HUMAN SUBJECTS: ETHICAL |
American Association For The Advancement Of |
OSSORIO, PILAR N |
42,507.00 |
|
| Msn/Med Sc/Surgery/Gen Surg |
MULTICENTER RANDOMIZED TRIAL OF DSRS VERSUS
TIPS |
Cleveland Clinic Foundation |
RIKKERS, LAYTON |
110,000.00 |
|
| Msn/Med Sc/Surgery/Thoracic S |
A DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY
AND |
Hoffmann-Laroche, Inc. |
LOVE, ROBERT B |
|
47,913.15 |
| Msn/Med Sc/Surgery/Transplant |
#2000-040 AN OPEN-LABEL, MULTICENTER STUDY
TO |
Ppd Development, Inc |
SOLLINGER, HANS W |
|
33,342.80 |
| Msn/Med Sc/Surgery/Transplant |
A COMPARATIVE, OPEN LABALE STUDY TO EVALUATE
GRAFT |
Ppd Development |
BECKER, YOLANDA T |
|
4,855.20 |
| Msn/Med Sc/Surgery/Transplant |
A RANDOMIZED, DOUBLE BLIND, MULTI-CENTER STUDY
OF |
Roche Global Development |
PIRSCH, JOHN D |
|
4,200.00 |
| Msn/Med Sc/Surgery/Transplant |
DERIVATION OF INSULIN PRODUCING BETA CELLS
FROM |
Roche Organ Transplantation Research Foundation |
ODORICO, JON S |
|
85,713.78 |
| Msn/Med Sc/Surgery/Transplant |
RAD1A06 A MULTICENTER, OPEN LABEL, EXPLORATORY |
Novartis |
ODORICO, JON S |
|
8,001.12 |
| Msn/Med Sc/Surgery/Transplant |
ANGIOTENSIN II RECEPTOR BLOCKADE AND CHRONIC |
Dhhs, Phs, National Institutes Of Health |
BECKER, BRYAN N |
210,000.00 |
|
| Msn/Med Sc/Surgery/Transplant |
IMMUNE REGULATION IN LUNG TRANSPLANTATION |
Dhhs, Phs, National Institutes Of Health |
BURLINGHAM, WILLIAM J |
288,000.00 |
|
| Msn/Med Sc/Surgery/Transplant |
SOLUBLE FORMS OF HLA-A B AND CHRONIC REJECTION |
Dhhs, Phs, National Institutes Of Health |
BURLINGHAM, WILLIAM J |
107,325.00 |
|
| Msn/Med Sc/Surgery/Urology |
10501 - A SINGLE BLIND, RANDOMIZED, MULTICENTER |
Vidamed, Inc. |
BRUSKEWITZ,
REGINALD C |
750.00 |
| Msn/Med Sc/Surgery/Urology |
A PHASE 11 STUDY OF THE SAFETY AND EFFICACY |
Alza Corporation |
MOON, TIMOTHY D |
|
2,090.40 |
| Msn/Med Sc/Surgery/Urology |
A RANDOMIZED PLACBO-CONTROLLED MULTICENTER
STUDY |
Merck & Co., Inc. |
MOON, TIMOTHY D |
|
15,321.64 |
| Msn/Med Sc/Surgery/Urology |
EFFICACY OF SELECTIVE COX-2 INHIBITORS IN THE |
Pharmacia |
NAKADA, STEPHEN Y |
|
9,481.00 |
| Msn/Med Sc/Surgery/Urology |
PHASE 111 RANDOMIZED, DOUBLE-BLIND STUDY OF |
Ilex Oncology, Inc. |
JARRARD, DAVID F |
|
250.00 |
| Msn/Psyc I/Psychiatric Inst/Psychiatri |
29060/651,A 12 WEEK, DOUBLE-BLIND, FIXED DOSE |
Smithkline Beecham |
KALIN, NED H |
|
5,179.48 |
| Msn/Psyc I/Psychiatric Inst/Psychiatri |
A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF
THE |
Ppd Development |
MARSHALL, JOHN |
|
45.00 |
| Msn/Psyc I/Psychiatric Inst/Psychiatri |
AN OPEN-LABEL RANDOMIZED ASSESSMENT OF THE |
Quintiles Pacific Inc. |
MARSHALL, JOHN |
|
12,377.00 |
| Msn/Psyc I/Psychiatric Inst/Psychiatri |
DULOXETINE VERSUS PLACEBO AND PAROXETINE IN
THE |
Quintiles Pacific, Inc |
MARSHALL, JOHN |
|
14,353.00 |
| Msn/Psyc I/Psychiatric Inst/Psychiatri |
GENE EXPRESSION PROFILE IN RESPONSE TO DRUG-PAIRED |
Dhhs, Phs, National Institutes Of Health |
LANDRY, CHARLES |
288,000.00 |
|
|
|
|
|
|
|
